The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Mar. 11, 2005
Applicants:

Stayajit Rohan Jayasinghe, Queensland, AU;

Suku Thambar, New South Wales, AU;

Inventors:

Stayajit Rohan Jayasinghe, Queensland, AU;

Suku Thambar, New South Wales, AU;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/24 (2006.01); A61F 2/848 (2013.01);
U.S. Cl.
CPC ...
A61F 2/2418 (2013.01); A61F 2/2436 (2013.01); A61F 2002/8486 (2013.01); A61F 2220/0016 (2013.01); A61F 2220/0058 (2013.01); A61F 2220/0075 (2013.01); A61F 2230/005 (2013.01); A61F 2230/0054 (2013.01); A61F 2230/0067 (2013.01);
Abstract

A percutaneous heart valve prosthesis () has a valve body () with a passage () extending between the first and second ends () of the valve body (). The valve body () is collapsible about a longitudinal axis () of the passage () for delivery of the valve body () via a catheter (). One or more flexible valve leaflets () are secured to the valve body () and extend across the passage () for blocking bloodflow in one direction through the passage (). An anchor device (), which is also collapsible for delivery via catheter (), is secured to the valve body () by way of an anchor line (). A failed or failing mitral heart valve () is treated by percutaneously locating the valve body () in the mitral valve orifice () with the anchor device () located in the right atrium () and engaging the inter-atrial septum (), such that the taught anchor line () acts to secure the valve body () within the mitral valve orifice ().

Published as:
AU2005221234A1; WO2005087140A1; WO2005087140A8; EP1734903A1; JP2007535342A; EP1734903A4; US2008243245A1; AU2005221234B2; AU2005221234C1; EP2308425A1; US8979922B2; US2015157458A1; EP1734903B1; US2017296339A1; EP3308744A1; US10085835B2; EP2308425B1; US10213298B2; US2019159896A1; EP3603576A1; EP3308744B1; EP3603576B1; US10993806B2; US2021236283A1; US11213390B2; EP1734903B2; US2022104942A1; US2023036489A1; US11622856B2; US2023233319A1; EP3308744B2; US11744705B2; EP2308425B2; US11974918B2;

Find Patent Forward Citations

Loading…